Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1B Business June 11, 2026 1 source Italian pharma company Angelini Pharma has acquired Catalyst Pharmaceuticals, a Florida-based rare-disease focused firm, for roughly $4.1 billion in cash.[38039]